Carbon-Negative Netherlands Biotech Company Coming to Canada

CANNABIS CULTURE – Netherlands-based biogenetics company  Perfect Plants (PP) is aiming to open a new location in the Greater Toronto Area.  They will be partnering with existing Canadian companies in developing and delivering sustainably produced plants, tissue, and seeds for agricultural use.  
“Plant-based medicine is a very important thing,” says Perfect Plants CEO Lenny Karmiol.  Karmiol says the focus needs to be bringing together molecular medicine and plant-based medicine.  “Half the world can’t be wrong, and more than half the world gets their primary medicine and pharmaceuticals from plants.” 
Not only does PP come to Canada with decades of experience in plant propagation, but they are also bringing their commitment to environmental protection.  in their Netherlands base, they utilize rainwater reservoirs, CO2 emissions from nearby companies, a co-generation plant, and a geothermal well.  They are 100% energy efficiency, generating their own heat and electricity for their entire 320,000 sq ft automated greenhouse and 45,000 sq ft laboratory, even having enough surplus to generate electricity for others and qualifying as carbon negative.  
These practices will be translated into the Canadian systems as well.  Recognizing that various points on the production chain are typically very specialized and separate, and that each company typically has a core specialization, finding strong partners and creating a stable and scalable ecosystem is the goal.  “Whenever we look for a perspective partner, we want to make sure they are as committed to sustainability as we are,” says Karmiol.    
Currently in Canada there are several companies working on similar projects.  Segra is a laboratory that produces tissue culture, and Mother works on creating pest and disease-free plants for both cannabis and hemp industries.  Even top growers such as Aurora are developing their own breeding program based on genomics.
Karmiol believes the cumulative result of cooperation over competition is much more successful, and they are approaching all the major growers in Canada.  “The best partner in any market is someone who is already in that marketplace.”  Despite there being many methods currently being employed, vertical integration can be challenging to maintain for any company, and “none of them can equal the consistency of growing from in-vitro or tissue culture starting material.  There will be a transition in the marketplace.”
The bulk of the next 2-3 years will be spent making sure that the Canadian companies who begin the transition have clear plans and are well prepared, as PP is invested in ensuring the successful continuity of the businesses.  They already hold contracts with a licensed producer in Ontario and a laboratory in Alberta, with 3 different companies in Canada actively negotiating deals.
Wayne Nathanson, President and COO of PP, told Cannabis Culture “while change does require energy and initial investment and adoption, the transition will ultimately increase profitability, significantly reduce risk, and allow growers to dramatically increase their revenue and efficiencies.”
By working together to share knowledge, standardize protocols, and grow genetic collections, Nathanson says, “our production partners and clients will be joining us in a platform that gives them access to world-leading practices, genetics, and international distribution opportunities.” 
The company currently produces more than 30 million plant products per year, and has 2 satellite laboratory sites that produce tissue culture in South Africa.  “We believe that we will be the first, and possibly the only company able to provide these commercial quantities to cannabis growers on a global basis,” said Nathanson.
Perfect Plants aims to expand the infrastructure for hemp, cannabis, and all food and pharma plants on a global basis, and make as many of the strong producers in markets their partners along the way.  As Karmiol concluded, “We would love to see a day where every high-quality consumer product for food or pharma somewhere on it says, ‘Powered by Perfect Plants.’”  
PP has been in the bio-genetics industry since 1980, and began to explore production of cannabis tissue 4 years ago.   According to CEO Lenny Karmiol, “the focus is on genetics, clean plant material, clean starts, and the delivery of that material to commercial growers.”
While cannabis has never been the sole focus of PP, their base in the pharmaceutical and food industry has meant that this is the next logical step in their development.  

Pass that dutch!
  • Date
  • Categories
    No Category